AJIC: American Journal of Infection Control
Volume 30, Issue 8 , Pages 476-489, December 2002

Guidelines for the prevention of intravascular catheter-related infections☆☆☆

Bethesda, Maryland; Cambridge, Worcester, and Boston, Massachusetts; Seattle, Washington; Atlanta, Georgia; Madison, Wisconsin; Providence, Rhode Island; Houston, Texas; and Chicago, Illinois

From the Clinical Center, National Institutes of Health, Bethesda, representing Society of Critical Care Medicine (SCCM) and Infectious Diseases Society of America (IDSA)a; Infusion Nurses Society (INS), Cambridgeb; Department of Surgery, University of Washington, Seattle, representing Surgical Infection Society (SIS) and SCCMc; Division of Healthcare Quality Promotion, National Center for Infectious Disease, CDC, Atlantad; Department of Anesthesiology, University of Massachusetts Medical School, Worcester, representing American College of Chest Physicians (ACCP) and American Society of Critical Care Anesthesiologists (ASCCA)e; Infectious Diseases Section, University of Wisconsin Medical School, Madisonf; University of Wisconsin Hospital and Clinics, Madison, representing Association for Professionals in Infection Control and Epidemiology (APIC)g; Division of Infectious Diseases, Rhode Island Hospital, and Brown University School of Medicine, Providenceh; Department of Medical Specialties, MD Anderson Cancer Center, Houstoni; Departments of Anesthesia and Pediatrics, the Children's Hospital, Bostonj; Division of Infectious Disease, Cook County Hospital and Rush Medical College, Chicago, representing Society for Healthcare Epidemiology of America (SHEA).k

Abstract 

Background: Although many catheter-related bloodstream infections (CR-BSIs) are preventable, measures to reduce these infections are not uniformly implemented. Objective: To update an existing evidenced-based guideline that promotes strategies to prevent CR-BSIs. Data Sources: The MEDLINE database, conference proceedings, and bibliographies of review articles and book chapters were searched for relevant articles. Studies Included: Laboratory-based studies, controlled clinical trials, prospective interventional trials, and epidemiological investigations. Outcome Measures: Reduction in CR-BSI, catheter colonization, or catheter-related infection. Synthesis: The recommended preventive strategies with the strongest supportive evidence are education and training of healthcare providers who insert and maintain catheters; maximal sterile barrier precautions during central venous catheter insertion; use of a 2% chlorhexidine preparation for skin antisepsis; no routine replacement of central venous catheters for prevention of infection; and use of antiseptic/antibiotic impregnated short-term central venous catheters if the rate of infection is high despite adherence to other strategies (i.e. education and training, maximal sterile barrier precautions and 2% chlorhexidine for skin antisepsis). Conclusion: Successful implementation of these evidence-based interventions can reduce the risk for serious catheter-related infection. (Am J Infect Control 2002;30:476-89.)

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 12.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

☆ *See list at end of article.

☆☆ This article is being published simultaneously in American Journal of Infection Control and Infection Control and Hospital Epidemiology . The full text of the Guidelines for the Prevention of Intravascular Catheter-Related Infections was published in the Morbidity and Mortality Weekly Report 2002; 51 (No. RR-10) and can be accessed at www.cdc.gov/ncidod/hip/default.htm .

PII: S0196-6553(02)00250-X

doi:10.1067/mic.2002.129427

AJIC: American Journal of Infection Control
Volume 30, Issue 8 , Pages 476-489, December 2002

Article Tools